Lupin Pharmaceuticals recalled 32,736 vials of Ganirelix Acetate Injection on November 13, 2025. The recall follows the discovery of impurities in the drug. Consumers and healthcare providers should stop using the product immediately to avoid health risks.
Failed impurities/degradation specifications: out of specification results for Ganirelix acetate acrylic acid adduct impurity.
Consumers and healthcare providers should stop using this product immediately. Contact Lupin Pharmaceuticals Inc. or your healthcare provider for guidance. Notification method: Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit
Get instant alerts for Health & Personal Care recalls
Be the first to know. Free instant alerts to your inbox.
Ganirelix Acetate Injection comes in a 250 mcg/0.5 mL single-dose sterile prefilled syringe with a 27 gauge by 1/2' needle. The affected lot number is WB00006, with an expiration date of December 31, 2026. The product was distributed in Florida, Massachusetts, Michigan, and Ohio.
The recall is due to failed impurities and degradation specifications, specifically out of specification results for Ganirelix acetate acrylic acid adduct impurity. This can pose significant health risks to patients.
Stop using Ganirelix Acetate Injection immediately. Contact Lupin Pharmaceuticals Inc. or your healthcare provider for guidance on the next steps.
For more information, consumers can visit the FDA's recall page or contact Lupin Pharmaceuticals directly.
Not sure what to do next? Our guide walks you through the process step by step.
Read: What to Do When You Find a Recalled ProductGet instant alerts for recalls that affect you. Free forever.
Honda recalls 2025 CR-V Hybrid vehicles sold through Honda dealers nationwide after finding an improperly installed fuel feed hose that may leak. The recall is identified by Honda as TLS. Dealers will replace the fuel feed hose and install a new connector cover at no charge. Owners should contact Honda at 1-888-234-2138 for service.
Volkswagen Group of America recalls 2023-2025 Atlas, Atlas Cross Sport and 2023-2024 ID.4 models for loose bolts in the chassis, brake system and suspension. The potential consequence is loss of vehicle control and a crash risk. Owners should stop driving the vehicle and contact a dealer for inspection; recall letters were mailed on July 25, 2025.
Mercedes-Benz USA is recalling certain 2024 GLE 350 4MATIC, 2025 GLE 450e 4MATIC, and additional models sold through its dealer network. The issue involves a multi-purpose camera and rearview mirror that may detach from the windshield. Dealers will replace the windshield and reinstall the camera and mirror at no charge.
Mazda North American Operations recalls 2024-2025 Mazda3 and CX-30 vehicles after SAS units may deactivate airbags due to a low battery condition. Dealers will reprogram the SAS unit or replace it at no charge. Owner notification letters were mailed July 24, 2025.
Kia America, Inc. recalled certain 2023-2025 K5 vehicles on April 7, 2027. The recall involves rear window trim pieces that may loosen and detach, creating a road hazard. Owners should contact Kia for inspection and potential replacement of affected parts.
Kia America, Inc. is recalling 2023-2025 Kia Telluride SUVs sold through Kia dealers nationwide after interim notices warned that door belt molding trim can delaminate and detach. A detached trim piece can become a road hazard for other vehicles and increase the risk of a crash. Owners should contact Kia customer service at 800-333-4542 for inspection and repair.
Ford Motor Company recalled certain 2024-2025 Expedition vehicles due to a misaligned engine cup plug. This defect can lead to rapid oil leaks, increasing the risk of engine stalls and fires. The recall affects models with 3.5L GTDI engines, with notifications mailed on May 22, 2025.
Volkswagen Group of America, Inc. recalled certain 2024-2025 Audi Q4 E-Tron models on April 2, 2027. The on-board charger may fail, leading to a loss of drive power. This defect increases the risk of a crash.